Customer Guest
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES 9. Verify Nomination in Account, click on link (:: Central Depository Services (India) Limited :: )
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Login | Register
Login | Register|Forgot password?
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Anuh Pharma Ltd 2...more...
Anuh Pharma Limited has informed the Exchange about Copy of Newspaper Publication for Second 100 Days Campaign - Saksham Niveshak.more...
As of March 2026 71.80% is owned by Promoters and 28.20% by Public. Among Promoters holding Indian Promoters holds 71.78% and Foreign Promoters holds...more...
Anuh Pharma Limited has informed the Exchange about Newspaper Publication regarding notice to shareholders for Special Window for transfer a...more...
Anuh Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations 2018more...
Compliance Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended 31st Marc...more...
Anuh Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015more...
Anuh Pharma Limited has informed the Exchange regarding Completion Of European Directorate For The Quality Of Medicines & Healthcare (EDQM) ...more...
Completion of European Directorate for the Quality of Medicines & Healthcare (EDQM) Audit and our facilities were found compliant under the Auditmore...
Investor Presentation for Q3 FY 2025-26more...
Anuh Pharma Limited has informed the Exchange about Investor Presentationmore...
Anuh Pharma Limited has informed the Exchange about Copy of Newspaper Publication of the Un-Audited financial results for the Quarter ended 31st Dece...more...
Completion of United States Food and Drug Administration (USFDA) Inspection with no Form 483 observations issued.more...
Anuh Pharma Limited has informed the Exchange regarding Completion of United States Food and Drug Administration (USFDA) inspection with no Form 483 ...more...
Granting Authorization to Key Managerial Personnel for determination of materiality of events/ information under Regulation 30 (5) of SEBI (...more...
Anuh Pharma Limited has informed the Exchange regarding Granting Authorization to Key Managerial Personnel for determination of materiality of events...more...
The company reported standalone net profit of Rs 13.45 crore for the quarter ended December 31 2025 as compared to Rs 10.34 crore in the sam...more...
Unaudited Financial Results for the quarter ended 31st December 2025more...
Anuh Pharma Limited has submitted to the Exchange the financial results for the period ended December 31 2025.more...
BOARD MEETINGS Company Name : Paisalo Digital Date : 10-05-2026